Urenheter av aminosyre brukt til syntetisering av protein
Produktdetaljer
| NO | Produkter | Cas nei | Nøkkelkvalitetsindikator | |||
| Renhet | Maks. urenhet | Total løsningsmiddelrest | Fuktighet | |||
| 1 | FMOC-ß-Ala-Ala-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 2 | FMOC-D-ALA-D-ALA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 3 | FMOC-ß-ALA-D-ALA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 4 | Fmoc-Arg (PBF) -Arg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 5 | FMOC-ß-Ala-Arg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 6 | FMOC-D-ARG (PBF) -D-ARG (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 7 | FMOC-ß-Ala-D-Arg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 8 | Fmoc-HomoArg (PBF) -HomoArg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 9 | FMOC-ß-Ala-HomoArg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 10 | Fmoc-asn (TRT) -ASN (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 11 | FMOC-ß-ALA-ASN (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 12 | Fmoc-Asp (otbu) -asp (otbu) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 13 | FMOC-ß-ALA-ASP (OTBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 14 | Fmoc-cys (TRT) -cys (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 15 | FMOC-ß-ALA-CYS (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 16 | Fmoc-cys (acm) -cys (acm) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 17 | FMOC-ß-ALA-CYS (ACM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 18 | Fmoc-gln (TRT) -gln (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 19 | FMOC-ß-ALA-GLN (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 20 | Fmoc-glu (otbu) -glu (otbu) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 21 | FMOC-ß-ALA-GLU (OTBU) -OH.H2O | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 22 | FMOC-ß-Ala-Gly-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 23 | Fmoc-His (TRT) -His (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 24 | FMOC-ß-Ala-His (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 25 | Fmoc-Ile-Ile-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 26 | FMOC-ß-Ala-Ile-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 27 | Fmoc-leu-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 28 | FMOC-ß-Ala-Leu-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 29 | Fmoc-d-leu-d-leu-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 30 | FMOC-ß-ALA-D-Leu-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 31 | FMOC-Lys (BOC) -LYS (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 32 | FMOC-ß-Ala-Lys (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 33 | Fmoc-lys (alloc) -lys (alloc) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 34 | FMOC-ß-Ala-Lys (Alloc) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 35 | Fmoc-met-met-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 36 | FMOC-ß-Ala-Met-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 37 | Fmoc-orn (BOC) -orn (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 38 | FMOC-ß-Ala-orn (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 39 | FMOC-Phe-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 40 | FMOC-ß-Ala-Phe-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 41 | FMOC-D-Phe-D-Phe-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 42 | FMOC-ß-ALA-D-Phe-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 43 | Fmoc-pro-pro-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 44 | FMOC-ß-Ala-Pro-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 45 | Fmoc-ser (tbu) -ser (tbu) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 46 | FMOC-ß-ALA-SER (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 47 | Fmoc-ser (TRT) -Ser (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 48 | FMOC-ß-ALA-SER (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 49 | Fmoc-thr (tbu) -thr (tbu) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 50 | FMOC-ß-Ala-thr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 52 | FMOC-ß-ALA-Trp (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 53 | FMOC-D-Trp (BOC) -D-Trp (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 54 | FMOC-ß-ALA-D-Trp (BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 55 | Fmoc-Tyr (TBU) -Tyr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 56 | FMOC-ß-Ala-Tyr (TBU) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 57 | Fmoc-D-Tyr (et) -D-Tyr (et) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 58 | FMOC-ß-ALA-D-TYR (ET) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 59 | Fmoc-Tyr (ME) -Tyr (ME) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 60 | FMOC-ß-Ala-Tyr (ME) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 61 | FMOC-Val-Val-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 62 | FMOC-ß-Ala-Val-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 63 | FMOC-D-CIT-D-CIT-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 64 | FMOC-ß-ALA-D-CIT-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 65 | FMOC-ß-ALA-DAB-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 66 | FMOC- (3- (2-naftyl) -D-Ala) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 67 | FMOC-ß-ALA-3- (2-naftyl) -D-ALA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 68 | Fmoc- (3- (3-pyridinyl) -D-Ala) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 69 | FMOC-ß-Ala-3- (3-pyridinyl) -D-Ala-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 70 | Fmoc- (4-klor-d-phe) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 71 | FMOC-ß-ALA-4-Chloro-D-Phe-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 72 | FMOC- (D-4APH (TBUCBM)) 2-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 73 | FMOC-ß-ALA-D-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 74 | Fmoc-af (l-hor) -af (l-hor) -oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 75 | FMOC-ß-ALA-APH (L-HOR) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 76 | FMOC-Lys (IPR, BOC) -LYS (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 77 | FMOC-ß-Ala-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 78 | FMOC-ß-ALA-AEEEA-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 79 | FMOC-AIB-AIB-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 80 | FMOC-ß-ALA-AIB-OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 81 | Fmoc-Arg-oh | 91000-69-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 82 | H-Arg (PBF) -OH | 200115-86-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 83 | FMOC-D-ARG-OH | 130752-32-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 84 | HD-Arg (PBF) -OH | 200116-81-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 85 | Fmoc-homoarg-oh.hcl | 208174-14-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 86 | H-homoarg (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 87 | Fmoc-d-homoarg-oh | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 88 | HD-HOMOARG (PBF) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 89 | Fmoc-asn-oh | 71989-16-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 90 | H-asn (TRT) -OH | 132388-58-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 91 | Fmoc-Asp-oh | 119062-05-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 92 | H-ASP (Otbu) -OH | 3057-74-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 93 | Fmoc-cys-oh | 135248-89-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 94 | H-Cys (TRT) -OH | 2799/7/7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 95 | H-Cys (ACM) -OH.HCL | 28798-28-9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 96 | Fmoc-gln-oh | 71989-20-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 97 | H-gln (TRT) -OH | 102747-84-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 98 | Fmoc-glu-oh | 121343-82-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 99 | H-glu (otbu) -oh.h2o | 2419-56-9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 100 | Fmoc-His-oh | 116611-64-4 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 101 | H-His (TRT) -OH | 35146-32-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 102 | Boc-His-Oh | 17791-52-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 103 | Fmoc-lys-oh | 105047-45-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 104 | H-Lys (BOC) -OH | 2418-95-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 105 | H-Lys (alloc) -OH | 6298/3/9 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 106 | Fmoc-orn-oh.hcl | 201046-57-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 107 | H-orn (BOC) -OH | 13650-49-2 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 108 | Fmoc-ser-oh | 73724-45-5 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 109 | H-ser (tbu) -oh | 18822-58-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 110 | H-ser (TRT) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 111 | Fmoc-thr-oh.h2o | 73731-37-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 112 | H-thr (tbu) -oh | 4378-13-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 113 | FMOC-TRP-OH | 35737-15-6 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 114 | H-Trp (BOC) -OH | 146645-63-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 116 | HD-Trp (BOC) -OH | 201290-11-1 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 117 | FMOC-TYR-OH | 92954-90-0 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 118 | H-Tyr (TBU) -OH | 18822-59-8 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 119 | FMOC-D-TYR-OH | 112883-29-1 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 120 | Hd-Tyr (et) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 121 | H-Tyr (ME) -OH.HCL | 67423-44-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 122 | FMOC-D-4APH (CBM) -OH | 324017-22-3 | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 123 | HD-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 124 | Fmoc-Lys (IPR) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
| 125 | H-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤ 1,0% | ≤8,0% | ≤2,0% |
Om
Kompensasjon
Gentolex gir produkter av god kvalitet, hvis noen produktkvalitet heves av klienten innenfor den nødvendige tidsrammen med tilstrekkelig bevis, vil vi gi nødvendig analyse og evaluering for å utløse prosedyrene for kompensasjoner.
Produksjon
Kapasitetene til farmasøytiske produkter nådde tonn karakter, kapasitetene til kjemiske produkter når 100 tons+ karakter, mulighetene er godt rustet til å betjene kunder over hele verden.
Forskning og utvikling
Hvert år er det planer satt opp av FoU -teamet for å utvikle forskjellige nye produkter, når mål satt, vil hvert medlem i teamet måtte fortsette med KPI -ansvar og med insentivpolitikk.
